Literature DB >> 22510624

Medical management of ectopic pregnancy.

Gary H Lipscomb1.   

Abstract

The use of medical management of ectopic pregnancy has become an accepted alternative to surgical therapy. Methotrexate, a folic acid antagonist, is the most widely studied agent. The most commonly used protocol consists of methotrexate 50 mg/m of actual body weight. Assessment of human chorionic gonadotropin (hCG) levels is repeated on days 4 and 7. Repeat methotrexate dosing is performed for hCG drops < 15%. Contraindications include hemodynamically unstable patients or those with elevated liver enzymes, low white blood count, or abnormal renal function. hCG levels are most predictive of success. A success rate of above 90% is achievable.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22510624     DOI: 10.1097/GRF.0b013e3182510a48

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  3 in total

1.  Conservative management of cervical pregnancy with intramuscular administration of methotrexate and KCl injection: Case report and review of the literature.

Authors:  Stamatios Petousis; Chrysoula Margioula-Siarkou; Ioannis Kalogiannidis; George Karavas; Vasileios Palapelas; Nikolaos Prapas; David Rousso
Journal:  World J Clin Cases       Date:  2015-01-16       Impact factor: 1.337

2.  Single-dose methotrexate for the treatment of ectopic pregnancy: Our experience from 2010 to 2015.

Authors:  Emre Erdem Tas; Gulin Feykan Yegin Akcay; Ayse Filiz Avsar
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

3.  The role of ultrasonography in methotrexate therapy for ectopic pregnancy.

Authors:  Piotr Czuczwar
Journal:  J Ultrason       Date:  2018
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.